Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Cold Spring Harbor Perspectives in Medicine
|
November 5, 2017
Efforts to Develop KRAS Inhibitors
Matthew Holderfield
Personalized Medicine
|
May 18, 2018
Progress in targeting RAF kinases for cancer therapy
Thomas J Turbyville, Matthew Holderfield
Nature Chemical Biology
|
December 17, 2016
RAS signaling: Divide and conquer
Matthew Holderfield, Deborah K Morrison
Nature Reviews. Cancer
|
June 25, 2014
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Matthew Holderfield, Marian M Deuker, Frank McCormick, et al.
Seminars in Cancer Biology
|
February 13, 2018
New weapons to penetrate the armor: Novel reagents and assays developed at the NCI RAS Initiative to enable discovery of RAS therapeutics
Dominic Esposito, Andrew G Stephen, Thomas J Turbyville, et al.
Cell
|
November 23, 2015
K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling
Man-Tzu Wang, Matthew Holderfield, Jacqueline Galeas, et al.
Sensors (Basel, Switzerland)
|
November 21, 2018
Label-Free Time-Gated Luminescent Detection Method for the Nucleotides with Varying Phosphate Content
Kari Kopra, Tanja Seppälä, Dana Rabara, et al.
Genome Biology
|
October 3, 2014
Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation
Claudia A Rubio, Benjamin Weisburd, Matthew Holderfield, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 16, 2019
KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis
Dana Rabara, Timothy H Tran, Srisathiyanarayanan Dharmaiah, et al.
Analytical Chemistry
|
February 29, 2020
Homogeneous Dual-Parametric-Coupled Assay for Simultaneous Nucleotide Exchange and KRAS/RAF-RBD Interaction Monitoring
Kari Kopra, Emmiliisa Vuorinen, Maria Abreu-Blanco, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Cold Spring Harbor Perspectives in Medicine
|
November 5, 2017
Efforts to Develop KRAS Inhibitors
Matthew Holderfield
Personalized Medicine
|
May 18, 2018
Progress in targeting RAF kinases for cancer therapy
Thomas J Turbyville, Matthew Holderfield
Nature Chemical Biology
|
December 17, 2016
RAS signaling: Divide and conquer
Matthew Holderfield, Deborah K Morrison
Nature Reviews. Cancer
|
June 25, 2014
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Matthew Holderfield, Marian M Deuker, Frank McCormick, et al.
Seminars in Cancer Biology
|
February 13, 2018
New weapons to penetrate the armor: Novel reagents and assays developed at the NCI RAS Initiative to enable discovery of RAS therapeutics
Dominic Esposito, Andrew G Stephen, Thomas J Turbyville, et al.
Cell
|
November 23, 2015
K-Ras Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling
Man-Tzu Wang, Matthew Holderfield, Jacqueline Galeas, et al.
Sensors (Basel, Switzerland)
|
November 21, 2018
Label-Free Time-Gated Luminescent Detection Method for the Nucleotides with Varying Phosphate Content
Kari Kopra, Tanja Seppälä, Dana Rabara, et al.
Genome Biology
|
October 3, 2014
Transcriptome-wide characterization of the eIF4A signature highlights plasticity in translation regulation
Claudia A Rubio, Benjamin Weisburd, Matthew Holderfield, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 16, 2019
KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis
Dana Rabara, Timothy H Tran, Srisathiyanarayanan Dharmaiah, et al.
Analytical Chemistry
|
February 29, 2020
Homogeneous Dual-Parametric-Coupled Assay for Simultaneous Nucleotide Exchange and KRAS/RAF-RBD Interaction Monitoring
Kari Kopra, Emmiliisa Vuorinen, Maria Abreu-Blanco, et al.
Page
of 4